<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03630406</url>
  </required_header>
  <id_info>
    <org_study_id>0022-18-RMB</org_study_id>
    <nct_id>NCT03630406</nct_id>
  </id_info>
  <brief_title>Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.</brief_title>
  <official_title>Vaginal Elasticity Assessment Before and After Vaginal Carbon Dioxide Laser Treatment.as Measured by Vaginal Tactile Imaging.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Female patients with either stress urinary incontinence (SUI) or vaginal wall weakness and
      prolapse will be evaluated for vaginal elasticity using vaginal tactile imaging both before
      and after Carbon Dioxide laser treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be recruited and sign a consent form. The patients included are patients with
      SUI or vaginal wall weakness and prolapse. Each participant undergoes 3 laser treatments 4
      weeks apart.

      Assessment of vaginal elasticity via vaginal tactile imaging will be performed at 3 different
      points:

        -  Before the first treatment session (baseline).

        -  Before and after each treatment session.

        -  3 months post final treatment. Every patient will serve as her own control. Demographic,
           gynecologic and obstetric history will be obtained from patients` electronic files.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Vaginal elasticity assessment</measure>
    <time_frame>up to 3 months from enrollment</time_frame>
    <description>Vaginal elasticity as measured by the vaginal tactile imager</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Laser Burn</condition>
  <arm_group>
    <arm_group_label>Laser treatment</arm_group_label>
    <description>Female patients with either SUI of vaginal wall weakness and prolapse refered for an attempt at laser treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Vaginal Tactile Imaging</intervention_name>
    <description>Vaginal Tactile Imaging</description>
    <arm_group_label>Laser treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients with either SUI or vaginal wall weakness and prolapse.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any woman undergoing vaginal Carbon Dioxide laser treatment.

        Exclusion Criteria:

          -  Women that are not in the age range.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roy Lauterbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roy Lauterbach, MD</last_name>
    <phone>972-52-9432416</phone>
    <email>r_lauterbach@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rambam health care campus</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roy Lauterbach, MD</last_name>
      <phone>0529432416</phone>
      <email>r_lauterbach@rambam.health.gov.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>August 10, 2018</study_first_submitted>
  <study_first_submitted_qc>August 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>November 13, 2019</last_update_submitted>
  <last_update_submitted_qc>November 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>ROY LAUTERBACH MD</investigator_full_name>
    <investigator_title>Primary Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

